PDA

View Full Version : Antibody-drug conjugates (ADCs): an interview with Dr Marco Timmers, CSO at Synthon B


News
02-20-2013, 07:11 AM
ADCs are used for a new type of targeted therapy that consists of a specific anti-cancer antibody or antibody fragment linked to a potent anti-cancer therapeutic.

More... (http://www.news-medical.net/news/20130220/Antibody-drug-conjugates-(ADCs)-an-interview-with-Dr-Marco-Timmers-CSO-at-Synthon-Biopharmaceuticals.aspx)